Triheptanoin (C7) has shown effectiveness in treating CoA dehydrogenase VLCAD deficiency, a type of LCFAOD. It has also shown to have greater efficacy than IMB-203. The study found that C7 reduced hepatic steatosis, whereas IMB-203 showed little to no effect.
Dr. Xue-Jun Zhao, MD of Children’s Hospital of Pittsburgh in Pennsylvania conducted the study which was presented at the 2022 INFORM lecture series.
Read the original article.